FR2980975B1 - Nouvelle composition dermatologique comprenant du tocopherol, un macerat huileux de fleurs de calendula dans de l'huile de rose musque, du palmitate de retinol et de l'ubiquinone - Google Patents

Nouvelle composition dermatologique comprenant du tocopherol, un macerat huileux de fleurs de calendula dans de l'huile de rose musque, du palmitate de retinol et de l'ubiquinone

Info

Publication number
FR2980975B1
FR2980975B1 FR1103018A FR1103018A FR2980975B1 FR 2980975 B1 FR2980975 B1 FR 2980975B1 FR 1103018 A FR1103018 A FR 1103018A FR 1103018 A FR1103018 A FR 1103018A FR 2980975 B1 FR2980975 B1 FR 2980975B1
Authority
FR
France
Prior art keywords
musky
ubiquinone
tocopherol
rose
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1103018A
Other languages
English (en)
Other versions
FR2980975A1 (fr
Inventor
Gilles Bhat
Jerome Didier Marc Grapinet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR1103018A priority Critical patent/FR2980975B1/fr
Publication of FR2980975A1 publication Critical patent/FR2980975A1/fr
Application granted granted Critical
Publication of FR2980975B1 publication Critical patent/FR2980975B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738—Rosa (rose)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
FR1103018A 2011-10-05 2011-10-05 Nouvelle composition dermatologique comprenant du tocopherol, un macerat huileux de fleurs de calendula dans de l'huile de rose musque, du palmitate de retinol et de l'ubiquinone Active FR2980975B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1103018A FR2980975B1 (fr) 2011-10-05 2011-10-05 Nouvelle composition dermatologique comprenant du tocopherol, un macerat huileux de fleurs de calendula dans de l'huile de rose musque, du palmitate de retinol et de l'ubiquinone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1103018A FR2980975B1 (fr) 2011-10-05 2011-10-05 Nouvelle composition dermatologique comprenant du tocopherol, un macerat huileux de fleurs de calendula dans de l'huile de rose musque, du palmitate de retinol et de l'ubiquinone

Publications (2)

Publication Number Publication Date
FR2980975A1 FR2980975A1 (fr) 2013-04-12
FR2980975B1 true FR2980975B1 (fr) 2016-08-26

Family

ID=45375332

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1103018A Active FR2980975B1 (fr) 2011-10-05 2011-10-05 Nouvelle composition dermatologique comprenant du tocopherol, un macerat huileux de fleurs de calendula dans de l'huile de rose musque, du palmitate de retinol et de l'ubiquinone

Country Status (1)

Country Link
FR (1) FR2980975B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3052067A1 (fr) * 2016-06-07 2017-12-08 Isispharma France Composition cosmetique ou dermatologique emolliente sous forme de spray pour le traitement des brulures superficielles, des irratations ou de forts etats de secheresse

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1313595B1 (it) * 1999-08-03 2002-09-09 Giorgio Panin Dispositivo per erogazione spray di una composizione per applicazionetopica comprendente vitamina e e acidi grassi essenziali.

Also Published As

Publication number Publication date
FR2980975A1 (fr) 2013-04-12

Similar Documents

Publication Publication Date Title
BR112014029762A2 (pt) composição contendo n-metil-n-acilglucamina
CL2013001947A1 (es) Composicion farmaceutica que comprende pioglitazona; uso de pioglitazona para tratar alzheimer; composicion que comprende pioglitazona.
CL2014000314A1 (es) Compuestos derivados de ciclopropanamina, inhibidores de desmetilasa especifica de lisina 1 (lsd1); medicamento que los comprende; metodo para profilaxis o tratamiento; metodo para inhibir lsd1; y su uso en la profilaxis o tratamiento de esquizofrenia, enfermedad de alzheimer, enfermedad de parkinson o corea de huntington.
BR112012012969A2 (pt) '' formulação farmacêutica líquida e uso de um antioxidante''
EA201290789A1 (ru) Термогелеобразующие композиции анестетиков
NZ702472A (en) Oil/water-emulsion-type topical compositions containing a retinoid
FR2988999B1 (fr) Composition cosmetique comprenant une huile essentielle particuliere et un ester d'acide amine et d'alcool gras
FR2998793B1 (fr) Composition cosmetique sous forme d'emulsion huile-dans-eau
CL2012003282A1 (es) Composicion farmaceutica topica que comprende, en base al peso total de la composicion a) 0,01 a 0,2% en peso de furoato de mometasona, b) 5 a 18% en peso de hexilenglicol, c) 20 a 40% en peso de agua y d) 25 a 70% en peso de una fase oleosa; y su uso para tratar o prevenir psoriasis, dermatitis atopica, entre otros.
BR112015006692A2 (pt) formulação de nanodispersão, método para administrar uma formulação de nanodispersão líquida de taxina livre de etanol em um indivíduo, e, kit.
BR112015013190A2 (pt) preparação cosmética ou dermatológica à base de uma emulsão de água-em-óleo, uso de uma preparação, e uso de pelo menos 0,1 % em peso
CL2015001881A1 (es) Compuesto 4-hidroxi-2-metil-5-(propan-2-iliden)ciclohexil-3-en-1-carbaldehido; uso del compuesto para el tratamiento de la enfermedad de alzheimer; composición farmacéutica; método para preparar la composición.
FR2991176B1 (fr) Compositions topiques, contenant un retinoide solubilise, de type gel hydroglycolique
FR2986693B1 (fr) Preparation huileuse comme substituant de l'huile de palme.
FR2980975B1 (fr) Nouvelle composition dermatologique comprenant du tocopherol, un macerat huileux de fleurs de calendula dans de l'huile de rose musque, du palmitate de retinol et de l'ubiquinone
FR2983731B1 (fr) Emulsions topiques a base de melanges eutectiques d'anesthesiques locaux et d'acide gras
FR2974296B1 (fr) Utilisation d'une combinaison d'un carotenoide, d'un phytoestrogene et de la vitamine c en tant qu'actif pour l'hydratation de la peau
FR2968989B1 (fr) Composition non rincee comprenant une laponite et une huile essentielle
FR2994528B1 (fr) Utilisation cosmetique de l'huile essentielle de laserpitium siler l. contre les signes cutanes du vieillissement.
FR3004940B1 (fr) Utilisation cosmetique d'une huile essentielle de satureja montana riche en geraniol comme actif deodorant
FR2993178B1 (fr) Composition cosmetique comprenant un extrait d'harungana madagascariensis
FR2994529B1 (fr) Utilisation cosmetique de l'huile essentielle de laserpitium siler l., a titre d'agent antioxydant.
FR2883183B1 (fr) Utilisation d'un extrait de dattes en tant qu'agent anti-oxydant
BR112015012267A2 (pt) formulação de fase líquido-cristalina oleosa contínua e uso das mesmas
FR2928837B1 (fr) Utilisation d'un extrait d'huile d'olive pour le controle du vieillissement cutane

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7